UROPLASTY INC-NEW (UPI)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
CEO:
Employees:
5420 FELTL ROAD, MINNETONKA, MN 55343
(952) 426-6140

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 27.018 Million Shares Outstanding22.146 Million Avg 30-day Volume 120.156 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.25
Price to Revenue1.7637 Debt to Equity0.0026 EBITDA-6.145 Million
Price to Book Value5.1896 Operating Margin-24.9357 Enterprise Value36.94 Million
Current Ratio3.186 EPS Growth-0.2 Quick Ratio2.954
1 Yr BETA 0.9347 52-week High/Low 0.0 / Profit Margin-25.2114
Operating Cash Flow Growth-34.1846 Free Cash Flow to Firm (FCFF) TTM -3.276 Million Free Cash Flow to Equity (FCFE) TTM-4.745 Million
Altman Z-Score1.9221
View SEC Filings from UPI instead.

View recent insider trading info

Funds Holding UPI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding UPI

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HOLMAN SUSAN HARTJES COO

  • Officer
498,650 2017-03-06 0

ROCHE KEVIN H

  • Director
0 2015-03-31 0

WEHRWEIN SVEN

  • Director
0 2015-03-31 0

REYNOLDS BRETT SR. VICE PRESIDENT AND CFO

  • Officer
0 2015-03-31 0

STAUNER JAMES P

  • Director
0 2015-03-31 0

KILL ROBERT PRESIDENT AND CEO

  • Officer
  • Director
0 2015-03-31 0

HAMMERS DARIN SR VP GLOBAL SALES & MARKETING

  • Officer
0 2015-03-31 0

PAULUS KENNETH H

  • Director
0 2015-03-31 0

JAMISON THOMAS EDWARD

  • Director
85,325 2014-08-19 0

LEE A JONES

  • Director
62,060 2014-08-19 0

MAXWELL ROBERT PATRICK

  • Director
151,584 2014-08-01 0

KOLB NANCY A VICEPRESIDENT GLOBAL MARKETING

  • Officer
47,557 2013-09-09 0

KAYSEN DAVID B PRESIDENT, CEO

  • Officer
109,375 2012-06-07 0

HEINEMANN LARRY R VICE PRESIDENT OF GLOBAL SALES

  • Officer
68,125 2012-06-07 0

KOOLE A J CONTROLLER, MANAGING DIRECTOR

  • Officer
7,666 2012-06-07 0

HERREGRAVEN MARC VICE PRESIDENT MANUFACTURING

  • Officer
46,125 2012-06-07 0

JIWANI MAHEDI A VICE PRESIDENT, CFO, TREASURER

  • Officer
42,100 2012-06-07 0

ROTH MICHAEL

STARK BRIAN JAY

  • 10% Owner
No longer subject to file 2009-02-17 0

TURN OF THE TIDE A WISCONSIN LP

HEARTLAND VALUE MANAGER LLC

NASGOVITZ WILLIAM J

  • NO LONGER A 10% OWNERNO LONGER A 10% OWNERNO LONGER A 10% OWNER
0 2007-05-29 0

TAPESTRY INVESTMENT PARTNERS LP

  • 10% Owner
1,219,300 2007-04-20 0

CYSTOMEDIX, INC.

  • 10% Owner
1,417,144 2007-04-06 0

MINDICH BRUCE P

  • 10% Owner
200,436 2006-09-14 0

HOLMAN DANIEL G

  • FORMER CEO AND BOARD MEMBER.
298,065 2006-05-24 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

No recent transactions

*** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

WhaleWisdom Logo

Elevate your investments